Cannabis Extract in Refractory Epilepsy Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The purpose of this study is to examine whether a low dose of CBD+THC will decrease the frequency of convulsive seizures in adults with drug-resistant epilepsy, when used in addition to standard anti-epileptic drugs (AEDs). This study will also study the genes associated with epilepsy and whether different epileptic syndromes respond to treatment with CBD+THC.
Epistemonikos ID: 53c1f0d5cb03ed155eb82ea7c93448917bfbec22
First added on: May 21, 2024